Remove Drug Development Remove Molecular Biology Remove RNA Remove Workshop
article thumbnail

Turning science into business: Merging AI and RNA

Drug Discovery World

DDW’s Diana Spencer speaks to Raphael Townshend PhD, Founder and CEO of Atomic AI, about the company’s successes so far, plans for the future and the unique approach of combining RNA structural biology and AI models. DS: How is Atomic AI “unlocking the next generation of RNA drug discovery”?

RNA 130
article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . Synthetic libraries for antibody drug discovery .

DNA 246